Surgery for Severe Mitral Regurgitation and Left Ventricular Failure: What Do We Really Know?

Journal of Cardiac Failure

Volumn 14, Issue 2, 2008, Pages 145-150

  Mehra, Mandeep R ^a   Reyes, Peter ^a   Benitez, R Michael ^a   Zimrin, David ^a   Gammie, James S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

annuloplasty; heart failure; Mitral regurgitation; surgical risk

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CHORDA TENDINEA; CLINICAL TRIAL; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFECT; HEALTH CARE QUALITY; HEART DILATATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART PAPILLARY MUSCLE; HEART VENTRICLE REMODELING; HUMAN; MITRAL ANNULOPLASTY; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MUSCLE WEAKNESS; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

AGED; BUNDLE-BRANCH BLOCK; DISEASE PROGRESSION; HEALTH STATUS INDICATORS; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MITRAL VALVE INSUFFICIENCY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME;

EID: 39749161541     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2007.10.008     Document Type: Review

References (41)

1. Jimenez J.H., Soerensen D.D., He Z., He S., and Yoganathan A.P. Effects of a saddle shaped annulus on mitral valve function and chordal force distribution: an in vitro study. Ann Biomed Eng 31 (2003) 1171-1181
2. Karagiannis S.E., Karatasakis G.T., Koutsogiannis N., Athanasopoulos G.D., and Cokkinos D.V. Increased distance between mitral valve coaptation point and mitral annular plane: significance and correlations in patients with heart failure. Heart 89 (2003) 1174-1178
3. Nielsen S.L., Nygaard H., Mandrup L., Fontaine A.A., Hasenkam J.M., He S., et al. Mechanism of incomplete mitral leaflet coaptation-interaction of chordal restraint and changes in mitral leaflet coaptation geometry. Insight from in vitro validation of the premise of force equilibrium. J Biomech Eng 124 (2002) 596-608
4. He S., Fontaine A.A., Schwammenthal E., Yoganathan A.P., and Levine R.A. Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies. Circulation 96 (1997) 1826-1834
5. Robbins J.D., Maniar P.B., Cotts W., Parker M.A., Bonow R.O., and Gheorghiade M. Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol 91 (2003) 360-362
6. Trichon B.H., Felker G.M., Shaw L.K., Cabell C.H., and O'Connor C.M. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 91 (2003) 538-543
7. Koelling T.M., Aaronson K.D., Cody R.J., Bach D.S., and Armstrong W.F. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 144 (2002) 524-529
8. Nieminen M.S., Brutsaert D., Dickstein K., Drexler H., Follath F., Harjola V.P., et al. EuroHeart Survey Investigators; Heart Failure Association, European Society of Cardiology. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27 (2006) 2725-2736
9. Levine R.A., and Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation 112 (2005) 745-758
10. Mehra M.R., Uber P.A., and Francis G.S. Heart failure therapy at a crossroad: are there limits to the neurohormonal model?. J Am Coll Cardiol 41 (2003) 1606-1610
11. Woo G.W., Petersen-Stejskal S., Johnson J.W., Conti J.B., Aranda Jr. J.A., and Curtis A.B. Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: analysis of the MIRACLE study. J Interv Card Electrophysiol 12 (2005) 107-113
12. Nemoto S., Hamawaki M., De Freitas G., and Carabello B.A. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation. J Am Coll Cardiol 40 (2002) 149-154
13. Capomolla S., Febo O., Gnemmi M., Riccardi G., Opasich C., Caporotondi A., et al. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J 139 (2000) 596-608
14. Lowes B.D., Gill E.A., Abraham W.T., Larrain J.R., Robertson A.D., Bristow M.R., et al. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol 83 (1999) 1201-1205
15. Zoghbi W.A., Enriquez-Sarano M., Foster E., Grayburn P.A., Kraft C.D., Levine R.A., et al. American Society of echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16 (2003) 777-802
16. Kotlyar E., Hayward C.S., Keogh A.M., Feneley M., and Macdonald P.S. The impact of baseline left ventricular size and mitral regurgitation on reverse left ventricular remodelling in response to carvedilol: size doesn't matter. Heart 90 (2004) 800-801
17. Rosario L.B., Stevenson L.W., Solomon S.D., Lee R.T., and Reimold S.C. The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size. J Am Coll Cardiol 32 (1998) 1819-1824
18. Breithardt O.A., Sinha A.M., Schwammenthal E., Bidaoui N., Markus K.U., Franke A., et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 41 (2003) 765-770
19. St John Sutton M.G., Plappert T., Abraham W.T., Smith A.L., DeLurgio D.B., Leon A.R., et al. Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107 (2003) 1985-1990
20. Kanzaki H., Bazaz R., Schwartzman D., Dohi K., Sade L.E., and Gorcsan III J. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: insights from mechanical activation strain mapping. J Am Coll Cardiol 44 (2004) 1619-1625
21. Lancellotti P., Melon P., Sakalihasan N., Waleffe A., Dubois C., Bertholet M., et al. Effect of cardiac resynchronization therapy on functional mitral regurgitation in heart failure. Am J Cardiol 94 (2004) 1462-1465
22. Bolling S.F., Deeb G.M., Brunsting L.A., and Bach D.S. Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. J Thorac Cardiovasc Surg 109 (1995) 676-682
23. Romano M.A., and Bolling S.F. Update on mitral repair in dilated cardiomyopathy. J Card Surg 19 (2004) 396-400
24. Bishay E.S., McCarthy P.M., Cosgrove D.M., Hoercher K.J., Smedira N.G., Mukherjee D., et al. Mitral valve surgery in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg 17 (2000) 213-221
25. De Bonis M., Lapenna E., La Canna G., Ficarra E., Pagliaro M., Torracca L., et al. Mitral valve repair for functional mitral regurgitation in end-stage dilated cardiomyopathy: role of the "edge-to-edge" technique. Circulation 112 9 Suppl (2005) I402-I408
26. Acker M.A., Bolling S., Shemin R., Kirklin J., Oh J.K., Mann D.L., et al. Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. J Thorac Cardiovasc Surg 132 (2006) 568-577
27. Spoor M.T., Geltz A., and Bolling S.F. Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair. Circulation 114 1 Suppl (2006) I67-I71
28. Haan C.K., Cabral C.I., Conetta D.A., Coombs L.P., and Edwards F.H. Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery. Ann Thorac Surg 78 (2004) 820-825
29. Gammie J.S., O'Brien S.M., Griffith B.P., Ferguson T.B., and Peterson E.D. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation 115 (2007) 881-887
30. Wu A.H., Aaronson K.D., Bolling S.F., Pagani F.D., Welch K., and Koelling T.M. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 45 (2005) 381-387
31. Mann D.L., Acker M.A., Jessup M., Sabbah H.N., Starling R.C., and Kubo S.H. Acorn Investigators and Study Coordinators. Rationale, design, and methods for a pivotal randomized clinical trial for the assessment of a cardiac support device in patients with New York health association class III-IV heart failure. J Card Fail 10 (2004) 185-192
32. Matsunaga A., Tahta S.A., and Duran C.M. Failure of reduction annuloplasty for functional ischemic mitral regurgitation. J Heart Valve Dis 13 (2004) 390-397 discussion 397-8
33. Kuwahara E., Otsuji Y., Iguro Y., Ueno T., Zhu F., Mizukami N., et al. Mechanism of recurrent/persistent ischemic/functional mitral regurgitation in the chronic phase after surgical annuloplasty: importance of augmented posterior leaflet tethering. Circulation 114 1 Suppl (2006) I529-I534
34. McGee E.C., Gillinov A.M., Blackstone E.H., Rajeswaran J., Cohen G., Najam F., et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 128 (2004) 916-924
35. Menicanti L., DiDonato M., Frigiola A., Buckberg G., Santambrogiion C., Ranucci M., and San D. RESTORE Group. Ischemic mitral regurgitation: Intraventricular papillary muscle imbrication without mitral ring during left ventricular restoration. J Thorac Cardiovasc Surg 123 (2002) 1041-1050
36. Kron I.L., Green G.R., and Cope J.T. Surgical relocation of the posterior papillary muscle in chronic ischemic mitral regurgitation. Ann Thorac Surg 74 (2002) 600-601
37. Messas E., Poiuzet B., Touchot B., Guerrero J.L., Vlahakes G.J., Desnos M., et al. Efficacy of chordal cutting to relieve chronic persistent ischemic mitral regurgitation. Circulation 108 II (2003) 11-15
38. Hvass U., Tapia M., Baron F., Pouzet B., and Shafy A. Papillary muscle sling: a new functional approach to mitral repair in patients with ischemic left ventricular dysfunction and functional mitral regurgitation. Ann Thorac Surg 75 (2003) 809-811
39. Langer F., and Schafers H.J. RING plus STRING: papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation. J Thorac Cardiovasc Surg 133 (2007) 247-249
40. Block P.C. Percutaneous mitral valve repair: are they changing the guard?. Circulation 111 (2005) 2154-2156
41. Feldman T., Wasserman H.S., Herrmann H.C., Gray W., Block P.C., Whitlow P., et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 46 (2005) 2134-2140